Benchmark restated a buy rating on Angi shares, and Truist Financial set a price objective on Angi shares.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Benchmark restated a buy rating on Angi shares, and Truist Financial set a price objective on Angi shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Angi
US-based website containing crowd-sourced reviews of local businesses (home services directory)
Nothing else this week.
-
Benchmark
venture capital firm
- The Bank of England, FED, and market experts are discussing how the ongoing Iran conflict and geopolitical tensions are driving up energy costs and influencing global financial rates.
- MarketBeat published a buy rating and target price increase for a company, with disclosures made under a Rule 10b5-1 trading plan.
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
Related events
- Benchmark restated a buy rating on Rambus shares.
- Truist Financial and Citigroup provided buy ratings and price objectives for Crown stock.
- Truist Financial boosted its price objective on Phreesia, Inc. shares.
- Truist Financial upped its price objective on Element Solutions Inc. stock on August 30, 2026.
- CoreCivic received a buy rating and boosted price objective from Benchmark, while MarketBeat published consensus rating data.